Table 4.
Relation between medical devices and adverse events.
| Total number of sessions performed | Adverse events, n (%) | |
|---|---|---|
| Medical devices in place during the session | ||
| Peripheral venous catheter, n | 582 | 13 (2.2%) |
| Arterial line | ||
| Total, n | 574 | 13 (2.3%) |
| Radial, n | 568 | 13 (2.3%) |
| Femoral, n | 6 | 0 (0%) |
| Central venous catheter | ||
| Total, n | 167 | 8 (4.8%) |
| Jugular, n | 112 | 5 (4.5%) |
| Subclavian, n | 18 | 0 (0%) |
| Femoral, n | 37 | 3 (8.1%) |
| Hemodialysis catheter | ||
| Total, n | 105 | 1 (1.0%) |
| Jugular, n | 96 | 1 (1.0%) |
| Femoral, n | 11 | 0 (0%) |
| Mechanical ventilator, n | 293 | 7 (2.4%) |
| Endotracheal tube, n | 183 | 5 (2.7%) |
| Tracheostomy tube, n | 127 | 3 (2.4%) |
| ECMO cannula, n | ||
| Total, n | 110 | 4 (3.6%) |
| Jugular, n | 110 | 4 (3.6%) |
| Femoral, n | 110 | 4 (3.6%) |
| Feeding tube, n | 419 | 10 (2.4%) |
| Urinary catheter, n | 550 | 12 (2.2%) |
| Chest tube, n | 83 | 3 (3.6%) |
| Abdominal drain, n | 112 | 2 (1.8%) |
| Total rehabilitation sessions | 587 | 13 (2.2%) |
Data are presented as number (%)
ECMO extracorporeal membrane oxygenation